18 June 2024
Transense Technologies plc
("Transense" or the "Company")
Director/PDMR shareholding - acquisition of shares
Transense Technologies plc, the provider of specialist sensor technology and measurement systems, has been notified that on 17 June 2024, Ryan Maughan, Managing Director, purchased 3,946 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 126.5 pence per share. Accordingly, Ryan Maughan's total beneficial shareholding in the Company has increased to 59,300 Ordinary Shares, which represents approximately 0.39% of the Company's current voting rights.
Further details are provided in the form below in accordance with the requirements of the UK Market Abuse Regulation.
For further information please visit www.transense.com or contact:
| Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (Chief Financial Officer) Ryan Maughan (Managing Director) | Via Walbrook PR |
| Allenby Capital (Nominated Adviser and Broker) Jeremy Porter/George Payne (Corporate Finance) Stefano Aquilino/Tony Quirke (Sales and Corporate Broking) | Tel: +44 (0)20 3328 5656 |
| Walbrook PR Tom Cooper/Nick Rome/Joesph Walker | Tel: +44 (0)20 7933 8780 Transense@walbrookpr.com |
Notes to Editors:
Transense is a developer of specialist sensor technology and measurement systems. The Company has two active business divisions:
· Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and
· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.
In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.
The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com
For further information please contact transense@walbrookpr.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |
| a)
| Name
| Ryan Maughan |
| 2
| Reason for the notification | |
| a)
| Position/status
| Managing Director |
| b)
| Initial notification /Amendment
| Initial |
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
| a)
| Name
| Transense Technologies plc |
| b)
| LEI
| 2138005N52J6KKQ3EY67 |
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
| a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 10 pence each |
| | | |
| Identification code | GB00BDHDTH21 | |
| | | |
| b)
| Nature of the transaction
| Purchase of Ordinary Shares |
| c) | Price and volume | Price: 126.5 pence per share
Volume: 3,946 |
| d)
| Aggregated information | |
| - Aggregated volume | As above | |
| - Price | | |
| | | |
| e)
| Date of the transaction
| 17 June 2024 |
| f)
| Place of the transaction
| London Stock Exchange, AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.